Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation
Brandenburger, A. Gheysen, G. Remaut, E. Soumillion, P. Van Doorsselaere, J. Custers, R.
Brandenburger, A.
Gheysen, G.
Remaut, E.
Soumillion, P.
Van Doorsselaere, J.
Custers, R.
Citations
Altmetric:
Abstract
This paper discusses regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis and provides scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation of GMOs.
Description
Date
2009-07-01
Journal Title
Journal ISSN
Volume Title
Publisher
ISBN
Chapter title
Publication type
Non-peer reviewed scientific publication
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
EU, mutagenesis, New techniques, Paper, regulation, Regulatory, SAFETY, SBB, Technique, use, website